AAAAAA
Results:
1-22
|
Results: 22
Authors:
Greub, G
Zysset, F
Genton, B
Spertini, F
Frei, PC
Citation: G. Greub et al., Absence of anti-hepatitis B surface antibody after vaccination does not necessarily mean absence of immune response, MED MICROBI, 189(3), 2001, pp. 165-168
Authors:
Kettner, A
Hughes, GJ
Frutiger, S
Astori, M
Roggero, M
Spertini, F
Corradin, G
Citation: A. Kettner et al., Api m 6: A new bee venom allergen, J ALLERG CL, 107(5), 2001, pp. 914-920
Authors:
Sauty, A
Colvin, RA
Wagner, L
Rochat, S
Spertini, F
Luster, AD
Citation: A. Sauty et al., CXCR3 internalization following T cell-endothelial cell contact: Preferential role of IFN-Inducible T cell alpha chemoattractant (CXCL11), J IMMUNOL, 167(12), 2001, pp. 7084-7093
Authors:
Jilek, S
Barbey, C
Spertini, F
Corthesy, B
Citation: S. Jilek et al., Antigen-independent suppression of the allergic immune response to bee venom phospholipase A(2) by DNA vaccination in CBA/J mice, J IMMUNOL, 166(5), 2001, pp. 3612-3621
Authors:
Lopez, JA
Weilenman, C
Audran, R
Roggero, MA
Bonelo, A
Tiercy, JM
Spertini, F
Corradin, G
Citation: Ja. Lopez et al., A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies (vol 31, pg 1989, 2001), EUR J IMMUN, 31(9), 2001, pp. 2839-2839
Authors:
Lopez, JA
Weilenman, C
Audran, R
Roggero, MA
Bonelo, A
Tiercy, JM
Spertini, F
Corradin, G
Citation: Ja. Lopez et al., A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies, EUR J IMMUN, 31(7), 2001, pp. 1989-1998
Authors:
Buclin, T
Spertini, F
Citation: T. Buclin et F. Spertini, Type IIFNs in human versus mouse, NAT IMMUNOL, 1(4), 2000, pp. 265-265
Authors:
Astori, M
von Garnier, C
Kettner, A
Dufour, N
Corradin, G
Spertini, F
Citation: M. Astori et al., Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice, J IMMUNOL, 165(6), 2000, pp. 3497-3505
Authors:
Aubert, V
Schneeberger, D
Sauty, A
Winter, J
Sperisen, P
Aubert, JD
Spertini, F
Citation: V. Aubert et al., Induction of tumor necrosis factor alpha and interleukin-8 gene expressionin bronchial epithelial cells by toxic shock syndrome toxin 1, INFEC IMMUN, 68(1), 2000, pp. 120-124
Authors:
von Garnier, C
Astori, M
Kettner, A
Dufour, N
Heusser, C
Corradin, G
Spertini, F
Citation: C. Von Garnier et al., Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis, EUR J IMMUN, 30(6), 2000, pp. 1638-1645
Authors:
Andreone, P
Spertini, F
Negro, F
Citation: P. Andreone et al., Lamivudine-associated remission of chronic hepatitis delta, ANN INT MED, 132(7), 2000, pp. 598-598
Authors:
Corthesy, B
Spertini, F
Citation: B. Corthesy et F. Spertini, Secretory immunoglobulin A: from mucosal protection to vaccine development, BIOL CHEM, 380(11), 1999, pp. 1251-1262
Authors:
Kettner, A
Henry, H
Hughes, GJ
Corradin, G
Spertini, F
Citation: A. Kettner et al., IgE and T-cell responses to high-molecular weight allergens from bee venom, CLIN EXP AL, 29(3), 1999, pp. 394-401
Authors:
Mayerat, C
Mantegani, A
Spertini, F
Frei, PC
Citation: C. Mayerat et al., Mutations in the basal core promoter and precore/core gene of hepatitis B virus in patients with chronic active but not acute hepatitis B, EUR J CL M, 18(12), 1999, pp. 871-878
Authors:
Bayer, PM
Bauerfeind, S
Bienvenu, J
Fabien, N
Frei, PC
Gilburd, B
Heide, KG
Hoier-Madsen, M
Meroni, PL
Monier, JC
Monneret, G
Panzeri, P
Shoenfeld, Y
Spertini, F
Wiik, A
Citation: Pm. Bayer et al., Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay, J AUTOIMMUN, 13(1), 1999, pp. 89-93
Authors:
Hammann, C
Genton, CY
Delabays, A
Delaloye, AB
Bogousslavsky, J
Spertini, F
Citation: C. Hammann et al., Myocarditis of mixed connective tissue disease: Favourable outcome after intravenous pulsed cyclophosphamide, CLIN RHEUMA, 18(1), 1999, pp. 85-87
Authors:
Spertini, F
Leimgruber, A
Morel, B
Khazaeli, MB
Yamamoto, K
Dayer, JM
Weisbart, RH
Lee, ML
Citation: F. Spertini et al., Idiotypic vaccination with a murine anti-dsDNA antibody: Phase I study in patients with nonactive systemic lupus erythematosus with nephritis, J RHEUMATOL, 26(12), 1999, pp. 2602-2608
Authors:
Tissot, JD
Invernizzi, F
Schifferli, JA
Spertini, F
Schneider, P
Citation: Jd. Tissot et al., Two-dimensional electrophoretic analysis of cryoproteins: A report of 335 samples, ELECTROPHOR, 20(3), 1999, pp. 606-613
Authors:
Rothuizen, LE
Buclin, T
Spertini, F
Trinchard, I
Munafo, A
Buchwalder, PA
Ythier, K
Biollaz, J
Citation: Le. Rothuizen et al., Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers, J NEUROIMM, 99(1), 1999, pp. 131-141
Authors:
Ganslmayer, M
Spertini, F
Rahm, F
Terrien, MH
Mosimann, B
Leimgruber, A
Citation: M. Ganslmayer et al., Evaluation of acoustic rhinometry in a nasal provocation test with allergen, ALLERGY, 54(9), 1999, pp. 974-979
Authors:
Terrien, MH
Rahm, F
Fellrath, JM
Spertini, F
Citation: Mh. Terrien et al., Comparison of the effects of terfenadine with fexofenadine on nasal provocation tests with allergen, J ALLERG CL, 103(6), 1999, pp. 1025-1030
Authors:
Seiler-Tuyns, A
Dufour, N
Spertini, F
Citation: A. Seiler-tuyns et al., Human tumor necrosis factor-alpha gene 3 ' untranslated region confers inducible toxin responsiveness to homologous promoter in monocytic THP-1 cells, J BIOL CHEM, 274(31), 1999, pp. 21714-21718
Risultati:
1-22
|